FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

FDA Approves Drug to Fight Complicated Urinary Tract Infections

Sept. 5, 2017
A A

The FDA approved Vabomere (meropenem and vaborbactam) for treating adults with complicated urinary tract infections, including pyeleonephritis, a bacterial infection of the kidneys.

Meropenem is an antibacterial and vaborbactam inhibits resistance to the drug by the bacteria.

Vabomere, administered by intravenous infusion, is sponsored by The Medicines Company.

View today's stories